Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (Minibody) is designed to be expressed as the anti-CA72-4 scFv fused to N-terminus of Knob-CH3 domain and the anti-CD3 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget T cells to tumor cells. It is designed for the research of Gastrointestinal cancer; Ovarian cancer; Colon cancer; Gastric cancer; Breast cancer; Adenocarcinomas therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY